Inflammation biotech Evommune…
Inflammation biotech Evommune plans to take the leap into public [...]
Sensei Biotherapeutics is…
Sensei Biotherapeutics is abandoning its sole clinical-stage drug and warning [...]
Takeda has given up on an…
Takeda has given up on an AstraZeneca-partnered neurological disorder program [...]
Roche’s Genentech unit is laying…
Roche’s Genentech unit is laying off staff at its Bay [...]
AbbVie has scrapped an asset from…
AbbVie has scrapped an asset from its ongoing collaboration with [...]
Novartis is pulling back the…
Novartis is pulling back the curtain on late-stage Sjögren’s wins, [...]
Eli Lilly and computing giant…
Eli Lilly and computing giant Nvidia are teaming up to [...]
Edesa Biotech has shared data from…
Edesa Biotech has shared data from its truncated phase 3 [...]
Aldeyra Therapeutics has shaken up…
Aldeyra Therapeutics has shaken up its drug development pipeline, stopping [...]
The number of biopharma M&A…
The number of biopharma M&A deals announced so far this [...]